FKBP5 and autoimmune polyendocrinopathy: These results are consistent with the pregnancy outcomes and placental characteristics observed in the Fkbp5-/- + APS group of mice, suggesting that SAFit2 may ameliorate pathological pregnancy injuries in OAPS by inhibiting the damaging effects of FKBP5 on the placenta, thereby improving overall pregnancy outcomes.